Linda Xiong Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Johnson Ridge Medical Park, Elkin, NC 28621 Phone: 336-526-4500 |
Asha B Thomas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Johnson Ridge Medical Park, Elkin, NC 28621 Phone: 336-526-4500 |
Destanae Davis, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Johnson Ridge Rd, Elkin, NC 28621 Phone: 336-527-7600 |
Lindsey Ruth Pack, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 331 Elk Spur St, Elkin, NC 28621 Phone: 276-791-4467 |
Sara Caitlin Plum, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1810 N Bridge St Ste 101, Elkin, NC 28621 Phone: 828-355-9584 Fax: 828-355-9689 |
Heathy Lymphatics Of Nc Pc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Chatham Medical Park, Elkin, NC 28621 Phone: 828-355-9584 Fax: 828-355-9689 |
Madison Hodges, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 560 Johnson Ridge Rd, Elkin, NC 28621 Phone: 336-835-7802 |
News Archive
Iconix Brand Group, Inc., today announced that it has signed a definitive agreement with United Features Syndicate, Inc. and The E.W. Scripps Company to acquire the Peanuts brand and related assets in partnership with the Schulz family.
Kaiser Health News staff writers Eric Pianin, Mary Agnes Carey and Julie Appleby combine efforts to provide this analysis of the reach of the public option in terms of its potential impact on the health care system.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's MerremĀ® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
A new study by U.S. and Chinese researchers, currently available on the bioRxiv* preprint server, demonstrates how cholesterol 25-hydroxylase and its enzymatic product 25-hydroxycholesterol can inhibit membrane fus
› Verified 3 days ago